Minerva Neurosciences, Inc. Gains 140.07%
Tue, Oct 21, 2025 at 07:18 PM
Minerva Neurosciences, Inc. (NERV:NASDAQ) soared at $6.41, representing a gain of 140.1%. On Tue, Oct 21, 2025, NERV:NASDAQ touched a New 2-Week High of $6.41. The stock appeared on our News Catalysts scanner on Tue, Oct 21, 2025 at 10:30 AM in the 'BIOTECH' category. From Tue, Oct 07, 2025, the stock recorded 60.00% Up Days and 72.73% Green Days
The stock spiked on Tue, Oct 21, 2025 at $12.46 with a volume of 165M+.
About Minerva Neurosciences, Inc. (NERV:NASDAQ)
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.
Top 10 Gainers:
- Beyond Meat, Inc. (BYND:NASDAQ), 146.26%
- Minerva Neurosciences, Inc. (NERV:NASDAQ), 140.07%
- rYojbaba Co. Ltd. (RYOJ:NASDAQ), 140%
- VSee Health, Inc. (VSEE:NASDAQ), 93.57%
- AlphaVest Acquisition Corp (ATMV:NASDAQ), 62.26%
- reAlpha Tech Corp. (AIRE:NASDAQ), 61.37%
- Emerson Radio Corp. (MSN:NYSEMKT), 59.31%
- Kuke Music Holding Limited (KUKE:NYSE), 39.18%
- BranchOut Food Inc. (BOF:NASDAQ), 33.65%
- Agroz Inc. (AGRZ:NASDAQ), 31.99%